Be Ready for “Doxy PEP” Orders to Prevent STIs
August 2024
Clinics and EDs will play a critical role in dispensing “doxy PEP”...to prevent sexually transmitted infections (STIs).
That’s because CDC now recommends doxycycline postexposure prophylaxis or “doxy PEP” in certain patients...to reduce the risk of getting an STI such as chlamydia, syphilis, or gonorrhea.
Think of this as similar to HIV postexposure prophylaxis (PEP)...where patients take meds ASAP after a possible exposure to prevent HIV.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote